Latest Articles
Zymeworks Announces First Patient Dosed in Phase 1 Clinical - GlobeNewswire
Zymeworks Announces First Patient Dosed in Phase 1 Clinical GlobeNewswire
Published: Nov. 5, 2024, 11:03 a.m.
Cardiac damage framework may identify patients who could benefit from earlier TAVR - MSN
Cardiac damage framework may identify patients who could benefit from earlier TAVR MSN
Published: Oct. 31, 2024, 6:39 a.m.
Women with Endometriosis Often Miss School and Work Due to Pain - Pain News Network
Women with Endometriosis Often Miss School and Work Due to Pain Pain News Network
Published: Oct. 28, 2024, 7:01 a.m.
Chemotherapy Combinations and the Phase 3 DUO-E Trial - Cancer Network
Chemotherapy Combinations and the Phase 3 DUO-E Trial Cancer Network
Published: Oct. 24, 2024, 6:32 p.m.
Neoadjuvant Treatment Considerations for Endometrial Cancer - Cancer Network
Neoadjuvant Treatment Considerations for Endometrial Cancer Cancer Network
Published: Oct. 24, 2024, 6:19 p.m.
Molecular Classification of Endometrial Cancer - Cancer Network
Molecular Classification of Endometrial Cancer Cancer Network
Published: Oct. 24, 2024, 6:19 p.m.
Overview of Endometrial Cancer - Cancer Network
Overview of Endometrial Cancer Cancer Network
Published: Oct. 24, 2024, 6:14 p.m.
Bayer, Dewpoint to work on heart drug; Viking’s obesity manufacturing plans - Endpoints News
Bayer, Dewpoint to work on heart drug; Viking’s obesity manufacturing plans Endpoints News
Published: Oct. 24, 2024, 2:27 p.m.
Danielle Collins postpones previously announced retirement - Big News Network
Danielle Collins postpones previously announced retirement Big News Network
Published: Oct. 18, 2024, 4:05 a.m.
Research Shifts Workplace View on Endometriosis - Mirage News
Research Shifts Workplace View on Endometriosis Mirage News
Published: Oct. 16, 2024, 4:42 a.m.
Link copied to clipboard!